Inicio › Enfermedades autoinmunes › Carolina del Norte › Durham
Ensayos clínicos de Enfermedades autoinmunes en Durham, NC
15 estudios para Enfermedades autoinmunes buscan participantes en centros de Durham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Environmental Risk Factors for the Anti-synthetase Syndrome
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · A 7 mi de distancia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ReclutandoFase 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
ReclutandoFase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · A 10 mi de distancia
Daratumumab in Primary Antiphospholipid Syndrome
ReclutandoFase 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
ReclutandoFase 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ReclutandoFase 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
ReclutandoFase 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
ReclutandoFase 1/2
- UNC Chapel Hill, Chapel Hill · A 10 mi de distancia
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutandoFase 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
ReclutandoFase 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
ReclutandoFase 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · A 10 mi de distancia
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
ReclutandoFase 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · A 10 mi de distancia
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
ReclutandoFase 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Duke University, Durham
Más información sobre Enfermedades autoinmunes en MedlinePlus
Ensayos de Enfermedades autoinmunes en otras ciudades
- Houston, TX21 estudios
- Washington, DC19 estudios
- New York City, NY19 estudios
- Philadelphia, PA16 estudios
- Boston, MA13 estudios
- Los Angeles, CA12 estudios
- Chicago, IL12 estudios
- Dallas, TX9 estudios
- Cleveland, OH8 estudios
- Atlanta, GA8 estudios
- Milwaukee, WI8 estudios
- Portland, OR8 estudios
Otros estudios en Durham
- Cáncer de seno63 estudios
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas39 estudios
- Mieloma múltiple37 estudios
- Cáncer metastásico33 estudios
- Leucemia mielógena aguda33 estudios
- Cáncer de pulmón32 estudios
- Cáncer de próstata32 estudios
- Cáncer del colon y del recto28 estudios
- Leucemia linfocítica crónica27 estudios
- Cáncer de ovario27 estudios
- Fallo cardíaco26 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.